NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Piramal Enterprises' pharma solutions division today said it aims to become the market leader in Antibody Drug Conjugates (ADCs) over the next five years. "We have set a target of becoming the market leader in ADCs contract commercialisation over the next five years. This is based on our focused investments…

news

Eli Lilly and Co and Incyte Corp said their experimental drug was found to be more effective in treating rheumatoid arthritis than a commonly prescribed medicine, in a late-stage study. The drug, baricitinib, reduced signs and symptoms of the inflammatory disorder better than the decades-old treatment, methotrexate, after 24 weeks,…

news

Drug major Sun Pharmaceutical Industries has made a tender offer to acquire US-based eyecare firm InSite Vision for USD 0.35 per share in cash. The company "has commenced a tender offer through its indirect wholly owned subsidiary, Thea Acquisition Corporation, for all of the outstanding shares of common stock of…

news

Eli Lilly and Company has entered into a settlement agreement to resolve patent litigation with Sanofi regarding its insulin glargine product, Basaglar®. As a part of the agreement, Lilly and its alliance partner, Boehringer Ingelheim, will have the ability to launch Basaglar in the U.S. on December 15, 2016. Under…

news

Drug firm Strides Arcolab plans to raise up to Rs 1,500 crore through various market instruments. "The Board of Directors of the company have approved the proposal to raise long term funds by way of issue of GDRs/ADRs /FCCBs/QIP or such other equity linked instruments as may be permissible for…

news

European pharmaceuticals group Sanofi on Tuesday said its application for review for its new drug, lixisenatide, a diabetes treatment, had been accepted by the U.S. Food and Drug Administration.   reuters.com

news

The U.S. Food and Drug Administration has revoked an approval issued in March to India's Sun Pharma Advanced Research Company Ltd (SPARC) to launch a drug for seizures, citing manufacturing quality problems at its production site. The move comes as a setback to SPARC, the research arm of India's largest…

news

Drug major Dr Reddy's Laboratories (DRL) has launched the generic version of Astrazeneca's Nexium, used to treat acid reflux, in the US market. In a BSE filing, DRL said "it has launched Esomeprazole magnesium delayed release capsules USP, 20 mg and 40 mg, a therapeutic equivalent generic version of Nexium…

news

AbbVie Inc said one of its experimental drugs improved symptoms of rheumatoid arthritis in mid-stage studies and scrapped plans to buy rights to a similar treatment from Belgium's Galapagos NV (GLPG.AS). Galapagos shares fell as much as 39 percent to 33.42 euros in Amsterdam on Friday, and were down 18…

news

Drug development company Rigel Pharmaceuticals Inc filed a lawsuit on Wednesday against Novartis AG, accusing the pharmaceutical giant of infringing on Rigel patents to make the cancer drug Zykadia. Novartis won U.S. approval for Zykadia, or ceritinib, in April 2014 and European approval in May of this year to treat…